Is kallikrein-8 a blood biomarker for detecting amnestic mild cognitive impairment? Results of the population-based Heinz Nixdorf Recall study

BACKGROUND: Kallikrein-8 (KLK8) might be an early blood-biomarker of Alzheimer’s disease (AD). We examined whether blood KLK8 is elevated in persons with amnestic mild cognitive impairment (aMCI) which is a precursor of AD, compared to cognitively unimpaired (CU) controls. METHODS: Forty cases and 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Schramm, Sara, Jokisch, Martha, Jöckel, Karl-Heinz, Herring, Arne, Keyvani, Kathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690879/
https://www.ncbi.nlm.nih.gov/pubmed/34930454
http://dx.doi.org/10.1186/s13195-021-00945-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690879/
https://www.ncbi.nlm.nih.gov/pubmed/34930454
http://dx.doi.org/10.1186/s13195-021-00945-x

Ejemplares similares